Corporate hedgers fear OTC liquidity drain

Increasing costs could force some end-users to abandon hedging, hurting swap market liquidity and forcing other firms to follow suit

money-down-drain
Hedgers fear OTC market could shrink in size

Increased regulatory and capital requirements on banks could result in a dangerous, downward spiral in over-the-counter markets, with some end-users abandoning certain products because of cost, which would hurt liquidity and force others to follow suit.

"If costs increase, there will be less OTC availability, which is a huge problem for end-users. It would do serious damage. And less availability would impact liquidity and increase costs further, resulting in less derivatives hedging, which will

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Risk.net? View our subscription options

The changing shape of risk

S&P Global Market Intelligence’s head of credit and risk solutions reveals how firms are adjusting their strategies and capabilities to embrace a more holistic view of risk

Most read articles loading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here